Lulin Huang Selected Research

Familial Exudative Vitreoretinopathies

6/2021	Whole-Exome Sequencing Reveals Novel TSPAN12 Variants in Autosomal Dominant Familial Exudative Vitreoretinopathy.
5/2021	Whole-Exome Sequencing Identified DLG1 as a Candidate Gene for Familial Exudative Vitreoretinopathy.
1/2021	Catenin α 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/β-catenin signaling.
2/2020	Identification of Novel Mutations in the FZD4 and NDP Genes in Patients with Familial Exudative Vitreoretinopathy in South India.
1/2020	Identification of novel variants in the FZD4 gene associated with familial exudative vitreoretinopathy in Chinese families.
1/2020	Exome sequencing revealed Notch ligand JAG1 as a novel candidate gene for familial exudative vitreoretinopathy.
7/2016	Whole Exome Sequencing Analysis Identifies Mutations in LRP5 in Indian Families with Familial Exudative Vitreoretinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lulin Huang Research Topics

Disease

7	Familial Exudative Vitreoretinopathies 06/2021 - 07/2016
4	Vascular Diseases (Vascular Disease) 05/2021 - 01/2020
3	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 10/2018
3	COVID-19 01/2022 - 01/2020
3	Blindness (Hysterical Blindness) 01/2021 - 01/2020
2	Neoplasms (Cancer) 08/2022 - 03/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 07/2018
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 01/2018
2	Kashin-Beck Disease 01/2013 - 11/2011
2	Infections 01/2012 - 12/2009
1	Lung Neoplasms (Lung Cancer) 08/2022
1	Gliosis 01/2022
1	Necrosis 01/2021
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 07/2020
1	Glaucoma 01/2020
1	Pathologic Neovascularization 01/2020
1	Retinal Diseases 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 09/2014
1	Stargardt Disease 01/2014
1	Myopia 01/2013

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 01/2022 - 07/2016
2	LigandsIBA 07/2020 - 01/2020
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 01/2018
2	HLA-DRB1 Chains (HLA DRB1)IBA 09/2014 - 11/2011
2	SeleniumIBA 01/2013 - 11/2011
2	IodineIBA 01/2013 - 11/2011
1	galactoglucanIBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AntigensIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	InterferonsIBA 01/2021
1	Cyclamates (Cyclamate)IBA 01/2021
1	tryptophanamideIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	CateninsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 11/2020
1	Polysaccharides (Glycans)IBA 11/2020
1	PectinsIBA 11/2020
1	Nicardipine (Dagan)FDA LinkGeneric 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 10/2018
1	GalactansIBA 07/2018
1	HDL CholesterolIBA 01/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2014
1	Staphylococcal Protein A (Protein A)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Selenoproteins (Selenoprotein)IBA 01/2013
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Bombyx mori moricin proteinIBA 12/2009
1	gloverinIBA 12/2009
1	Peptides (Polypeptides)IBA 12/2009

Therapy/Procedure

3	Therapeutics 08/2022 - 03/2018